<DOC>
	<DOCNO>NCT01593488</DOCNO>
	<brief_summary>The purpose study describe activity toxicity new formulation cytarabine call liposomal cytarabine give central nervous system treatment central nervous system localization acute lymphoblastic leukemia ( ALL ) child adolescent .</brief_summary>
	<brief_title>Liposomal Cytarabine Treatment Central Nervous System Resistant Relapsed Acute Lymphoblastic Leukemia Children</brief_title>
	<detailed_description>Liposomal cytarabine ( DepoCyte ) new formulation drug cytarabine , drug commonly use treatment ALL . This formulation drug give intrathecally ( spinal fluid ) , release slowly longer period , two week . This allow long exposure drug central nervous system , require few intrathecal injection patient .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Age &lt; 18 year Diagnosis acute lymphoblastic leukemia ( ALL ) Central nervous system involvement malignant cell present cerebrospinal fluid CNS involvement may refractive prior systemic therapy , first recurrence prior systemic intrathecal therapy second recurrence CNS involvement may isolate lesion present site disease ECOG performance status 02 Life expectancy least 8 week Absence severe organ dysfunction Informed consent Eligibility AIEOP study first recurrence ALL , receive therapy center participate AIEOP study Concurrent treatment experimental therapy Severe neurologic toxicity previous chemotherapy Severe coagulopathy time recurrence Sepsis Intrathecal therapy within 1 week plan study therapy Total body head spine radiation within 8 week enrolment Bone marrow transplant within 8 week start study therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>recurrent</keyword>
	<keyword>CNS disease</keyword>
	<keyword>intrathecal therapy</keyword>
</DOC>